Prudential Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-9,627
| Closed | -$607K | – | 2730 |
|
|
2021
Q4 | $607K | Sell |
9,627
-8,154
| -46% | -$537K | ﹤0.01% | 2130 |
|
|
2021
Q3 | $1.08M | Buy |
17,781
+575
| +3% | +$34K | ﹤0.01% | 1764 |
|
|
2021
Q2 | $1.17M | Buy |
17,206
+12,010
| +231% | +$783K | ﹤0.01% | 1759 |
|
|
2021
Q1 | $360K | Sell |
5,196
-4,046
| -44% | -$311K | ﹤0.01% | 2229 |
|
|
2020
Q4 | $711K | Sell |
9,242
-961
| -9% | -$72K | ﹤0.01% | 1912 |
|
|
2020
Q3 | $763K | Sell |
10,203
-5,733
| -36% | -$382K | ﹤0.01% | 1780 |
|
|
2020
Q2 | $1M | Buy |
15,936
+7,003
| +78% | +$385K | ﹤0.01% | 1640 |
|
|
2020
Q1 | $375K | Sell |
8,933
-2,093
| -19% | -$96K | ﹤0.01% | 1992 |
|
|
2019
Q4 | $500K | Sell |
11,026
-2,525
| -19% | -$119K | ﹤0.01% | 2059 |
|
|
2019
Q3 | $620K | Sell |
13,551
-96,638
| -88% | -$5.43M | ﹤0.01% | 1992 |
|
|
2019
Q2 | $6.46M | Sell |
110,189
-13,437
| -11% | -$694K | 0.01% | 1033 |
|
|
2019
Q1 | $5.54M | Buy |
123,626
+117,564
| +1,939% | +$5.39M | 0.01% | 1098 |
|
|
2018
Q4 | $236K | Buy |
6,062
+543
| +10% | +$21.3K | ﹤0.01% | 2197 |
|
|
2018
Q3 | $254K | Buy |
5,519
+140
| +3% | +$5.67K | ﹤0.01% | 2257 |
|
|
2018
Q2 | $235K | Buy |
+5,379
| New | +$231K | ﹤0.01% | 2290 |
|
|
2017
Q2 | – | Sell |
-2,659
| Closed | -$39K | – | 2389 |
|
|
2017
Q1 | $39K | Hold |
2,659
| – | – | ﹤0.01% | 2313 |
|
|
2016
Q4 | $38K | Hold |
2,659
| – | – | ﹤0.01% | 2317 |
|
|
2016
Q3 | $47K | Buy |
2,659
+146
| +6% | +$2.42K | ﹤0.01% | 2302 |
|
|
2016
Q2 | $43K | Buy |
2,513
+70
| +3% | +$1.25K | ﹤0.01% | 2273 |
|
|
2016
Q1 | $48K | Buy |
2,443
+40
| +2% | +$641 | ﹤0.01% | 2271 |
|
|
2015
Q4 | $46K | Sell |
2,403
-50
| -2% | -$1.02K | ﹤0.01% | 2209 |
|
|
2015
Q3 | $47K | Buy |
2,453
+30
| +1% | +$1.02K | ﹤0.01% | 2196 |
|
|
2015
Q2 | $112K | Sell |
2,423
-50
| -2% | -$2.17K | ﹤0.01% | 2184 |
|
|
2015
Q1 | $108K | Buy |
2,473
+130
| +6% | +$6.04K | ﹤0.01% | 2185 |
|
|
2014
Q4 | $81K | Sell |
2,343
-470
| -17% | -$19.1K | ﹤0.01% | 2158 |
|
|
2014
Q3 | $118K | Sell |
2,813
-2,739
| -49% | -$122K | ﹤0.01% | 2162 |
|
|
2014
Q2 | $325K | Buy |
5,552
+2,729
| +97% | +$172K | ﹤0.01% | 2163 |
|
|
2014
Q1 | $178K | Sell |
2,823
-410
| -13% | -$27.2K | ﹤0.01% | 2179 |
|
|
2013
Q4 | $189K | Sell |
3,233
-190
| -6% | -$9.93K | ﹤0.01% | 2188 |
|
|
2013
Q3 | $180K | Buy |
3,423
+40
| +1% | +$2.69K | ﹤0.01% | 2181 |
|
|
2013
Q2 | $260K | Buy |
+3,383
| New | +$276K | ﹤0.01% | 2112 |
|
Prudential Financial's ARNA Position: Q1 2022 in Review
Prudential Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 9,627 shares — an estimated $607K sold.
Prudential Financial first reported a position in ARNA in Q2 2013 and held it in 31 quarters. The position peaked at $6.46M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Prudential Financial reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Prudential Financial sold 9,627 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $607K.
- Prudential Financial first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 31 quarters.
- Prudential Financial's Arena Pharmaceuticals Inc position peaked at $6.46M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Prudential Financial's 13F filing for Q1 2022, filed 13 May 2022.